Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Emgdi Regulatory News (JEMI)

Share Price Information for Jpmorgan Emgdi (JEMI)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -3.00 (-1.41%)
Bid:
210.00
Ask:
213.00
Spread: 3.00 (1.429%)
Market Cap: £545.62m
JEMI Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Emgdi Share Chart

Director Declaration

20 Aug 2024 08:49

RNS Number : 0893B
JPMorgan Global Emerging Mkts I.T.
20 August 2024
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL EMERGING MARKETS INCOME TRUST PLC

(the "Company")

 

DIRECTOR DECLARATION

 

Legal Entity Identifier: 549300OPJXU72JMCYU09

Information disclosed in accordance with Listing Rule 9.6.14

 

 

The Board of the Company announces that with effect from 1st October 2024, Ranjan Ramparia has been appointed as non-executive director of Keystone Positive Change Investment Trust plc.

 

20th August 2024

 

For further information, please contact:

 

Emma Lamb

For and on behalf of

JPMorgan Funds Limited, Secretary

0800 20 40 20

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNPMMRTMTITMPI
Date   Source Headline
9th Mar 202610:44 amRNSNet Asset Value(s)
6th Mar 202611:33 amRNSNet Asset Value(s)
5th Mar 202610:54 amRNSNet Asset Value(s)
4th Mar 202611:49 amRNSNet Asset Value(s)
3rd Mar 202611:28 amRNSNet Asset Value(s)
2nd Mar 202612:57 pmRNSGearing Announcement
2nd Mar 202611:25 amRNSNet Asset Value(s)
27th Feb 202610:46 amRNSNet Asset Value(s)
26th Feb 202610:38 amRNSNet Asset Value(s)
26th Feb 20267:00 amRNSDividend Declaration
25th Feb 202610:21 amRNSNet Asset Value(s)
24th Feb 202610:43 amRNSNet Asset Value(s)
23rd Feb 20262:07 pmRNSGearing Announcement
23rd Feb 202611:24 amRNSNet Asset Value(s)
20th Feb 202611:06 amRNSNet Asset Value(s)
19th Feb 202610:42 amRNSNet Asset Value(s)
18th Feb 202610:26 amRNSNet Asset Value(s)
17th Feb 202610:52 amRNSNet Asset Value(s)
16th Feb 202611:44 amRNSGearing Announcement
16th Feb 202611:24 amRNSNet Asset Value(s)
13th Feb 202611:21 amRNSNet Asset Value(s)
13th Feb 202610:31 amRNSTen Largest Investments
12th Feb 202611:10 amRNSNet Asset Value(s)
11th Feb 202610:42 amRNSNet Asset Value(s)
10th Feb 202610:46 amRNSNet Asset Value(s)
9th Feb 202611:29 amRNSGearing Announcement
9th Feb 202610:59 amRNSNet Asset Value(s)
6th Feb 202610:49 amRNSNet Asset Value(s)
5th Feb 202611:49 amRNSNet Asset Value(s)
4th Feb 202611:41 amRNSNet Asset Value(s)
3rd Feb 202611:07 amRNSNet Asset Value(s)
2nd Feb 20263:35 pmRNSClosed Period Notification
2nd Feb 202612:40 pmRNSGearing Announcement
2nd Feb 202611:36 amRNSNet Asset Value(s)
30th Jan 202611:20 amRNSNet Asset Value(s)
29th Jan 20266:00 pmRNSDowlais Group - Update
29th Jan 202611:01 amRNSNet Asset Value(s)
28th Jan 202611:42 amRNSNet Asset Value(s)
27th Jan 202610:36 amRNSNet Asset Value(s)
26th Jan 202611:16 amRNSGearing Announcement
26th Jan 202610:52 amRNSNet Asset Value(s)
23rd Jan 202610:36 amRNSNet Asset Value(s)
22nd Jan 202611:11 amRNSNet Asset Value(s)
21st Jan 202610:42 amRNSNet Asset Value(s)
20th Jan 202610:59 amRNSNet Asset Value(s)
19th Jan 202611:25 amRNSGearing announcement
19th Jan 202610:55 amRNSNet Asset Value(s)
19th Jan 20267:00 amRNSChange of Name
16th Jan 202611:04 amRNSNet Asset Value(s)
15th Jan 202610:54 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.